2021 annual financial data

Enliven Therapeutics, Inc. 2021 Operating margin

Enliven Therapeutics, Inc. 2021 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -24,762,000 USD and net income was -24,740,000 USD.
Operating cash flow was -19,134,000 USD.

Get free Enliven Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-24,762,000 USD
Net income
-24,740,000 USD
Operating cash flow
-19,134,000 USD